These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10790102)

  • 41. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.
    Schmitz FJ; MacKenzie CR; Geisel R; Wagner S; Idel H; Verhoef J; Hadding U; Heinz HP
    Eur J Epidemiol; 1997 Sep; 13(6):699-708. PubMed ID: 9324218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A toroid model for in vitro investigations of toxic shock syndrome toxin-1 production.
    Flood JA; Tripp TJ; Davis CC; Hill DR; Schlievert PM
    J Microbiol Methods; 2004 May; 57(2):283-8. PubMed ID: 15063069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Wong AC; Downs SA
    J Clin Microbiol; 1989 Nov; 27(11):2482-7. PubMed ID: 2808672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxin involvement in toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. On the pathogenesis of toxic shock syndrome.
    Kass EH; Parsonnet J
    Rev Infect Dis; 1987; 9 Suppl 5():S482-9. PubMed ID: 3317745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of enterotoxins and TSST-1 secreted by Staphylococcus aureus isolated from ruminant mastitis. Comparison of ELISA and immunoblot.
    Orden JA; Goyache J; Hernández J; Doménech A; Suárez G; Gómez-Lucía E
    J Appl Bacteriol; 1992 Jun; 72(6):486-9. PubMed ID: 1644704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus restricted to endogenous air in tampons.
    Reiser RF; Hinzman SJ; Bergdoll MS
    J Clin Microbiol; 1987 Aug; 25(8):1450-2. PubMed ID: 3624443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.
    Parsonnet J; Gillis ZA; Pier GB
    J Infect Dis; 1986 Jul; 154(1):55-63. PubMed ID: 3486924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins.
    Schlievert PM
    J Am Coll Surg; 1996 Jul; 183(1):19-24. PubMed ID: 8673303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of topical antimicrobial agents on the production of toxic shock syndrome toxin-1.
    Edwards-Jones V; Foster HA
    J Med Microbiol; 1994 Dec; 41(6):408-13. PubMed ID: 7966218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PCR detection of toxic shock syndrome toxin of Staphylococcus aureus from Tripoli, Libya.
    El-Ghodban A; Ghenghesh KS; Márialigeti K; Esahli H; Tawil A
    J Med Microbiol; 2006 Feb; 55(Pt 2):179-182. PubMed ID: 16434710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of magnesium on production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus.
    Schlievert PM
    J Infect Dis; 1985 Sep; 152(3):618-20. PubMed ID: 4031559
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro.
    Parsonnet J; Modern PA; Giacobbe KD
    J Infect Dis; 1996 Jan; 173(1):98-103. PubMed ID: 8537689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of silver sulphadiazine on the production of exoproteins by Staphylococcus aureus.
    Edwards-Jones V; Foster HA
    J Med Microbiol; 2002 Jan; 51(1):50-55. PubMed ID: 11800472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
    De Boer ML; Kum WW; Pang LT; Chow AW
    Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A study of virulence factors produced by MRSA strains isolated from blood samples].
    Mizukane R; Nakatomi M; Futsuki Y; Araki J; Asai S; Sawatari K; Hirakata Y; Maesaki S; Tomono K; Kohno S
    Kansenshogaku Zasshi; 1998 Aug; 72(8):788-93. PubMed ID: 9780580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus.
    MacPhee RA; Miller WL; Gloor GB; McCormick JK; Hammond JA; Burton JP; Reid G
    Appl Environ Microbiol; 2013 Mar; 79(6):1835-42. PubMed ID: 23315732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of tampon wraps on production of toxic shock syndrome toxin 1.
    Robbins RN; Kelly BJ; Hehl GL; Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S197-202. PubMed ID: 2928637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency of nasal and wound isolates of Staphylococcus aureus associated with TSST-1 production in Jordanian population.
    Daghistani HI; Issa AA; Shehabi AA
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):95-8. PubMed ID: 10640602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inverse relationship between toxic shock syndrome toxin-1 antibodies and interferon-γ and interleukin-6 in peripheral blood mononuclear cells from patients with pediatric tonsillitis caused by Staphylococcus aureus.
    Chen Y; Huang Y; Liang B; Dong H; Yao S; Xie Y; Long Y; Zhong H; Yang Y; Zhu B; Gong S; Zhou Z
    Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():211-217. PubMed ID: 28483238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.